MMedication Read More Mark Cuban tries to shake up biosimilar pricing with a version of J&J’s StelaraNovember 6, 2025 In its latest bid to shake up the prescription drug market, the Mark Cuban Cost Plus Drug Company…
MMedication Read More New FDA priority review vouchers go to Lilly, Novo, VertexNovember 6, 2025 WASHINGTON — The Food and Drug Administration on Thursday announced the second batch of companies being granted a “Commissioner’s…
MMedication Read More Teva recalls blood pressure medication over cancer-causing chemicalsNovember 6, 2025 New guidelines reveal how to lower blood pressure The American Heart Association and the American College of Cardiology…
MMedication Read More Atorvastatin recall 2025: FDA recalls over 140,000 bottles of cholesterol drug over dissolution failureNovember 6, 2025 1Atorvastatin Calcium Tablets USP, 10 mg, Rx Only a) 90-count bottle (NDC 67877-511-90), b). 500-count bottle (NDC 67877-511-05),…
MMedication Read More Trump seeks lower prices for Wegovy, ZepboundNovember 6, 2025 President Donald Trump announces plan to expand IVF access President Donald Trump announced a plan to expand IVF…
EEnvironment Read More Tokushima company develops bear repellent spray amid record attack numbersNovember 4, 2025 As Japan grapples with a record number of fatal bear attacks, a small company in Tokushima Prefecture has…
HHealthcare Read More Pfizer files second lawsuit against Novo Nordisk, MetseraNovember 3, 2025 A Pfizer logo is displayed at a research facility in the La Jolla neighborhood of San Diego, California,…
HHealthcare Read More Eli Lilly (LLY) earnings Q3 2025October 30, 2025 A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March…
MMedication Read More Bayer’s Lynkuetâ„¢ (elinzanetant) approved in the U.S. for treatment of moderate to severe vasomotor symptoms due to menopauseOctober 30, 2025 Berlin, October 24, 2025 – Bayer announced today that the U.S. Food and Drug Administration (FDA) has approved…
MMedication Read More Is Your Medication Made in a Contaminated Factory? The FDA Won’t Tell YouOctober 25, 2025 ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like…
MMedication Read More I’m stuck in the gray market for GLP-1sOctober 24, 2025 On Oct. 16, President Trump promised to slash the price of brand-name GLP-1 drugs like Ozempic and Wegovy…
MMedication Read More Launch prices for new drugs ‘significantly’ exceed inflation, analysis saysOctober 23, 2025 Amid intensifying angst over prescription drug prices, a new analysis found that the median net price for 154…